Colony Formation Assay Protocol: Measuring Cell Reproductive Viability

The colony formation assay (also called clonogenic assay or colony counting assay) is a cell-based method that measures the ability of single cells to proliferate into macroscopic colonies, thereby quantifying reproductive viability. This assay is essential for evaluating the long-term cytotoxic or anti-proliferative effects of treatments, as it captures cells that retain the capacity for sustained division—a more stringent endpoint than short-term viability assays. It is widely used in cancer research to assess drug efficacy, radiation sensitivity, and gene function studies, as demonstrated in investigations of silibinin in pharyngeal carcinoma cells [1], sanguinarine chloride in endometrial cancer [2], and ORC6L in breast cancer [3]. The protocol is suitable for BSL-1 routine cell culture work with non-pathogenic, established cell lines.

At a Glance

Scientific Principle

The colony formation assay is based on the principle that a single viable cell can divide and form a visible colony (typically ≥50 cells) when cultured under optimal conditions. This endpoint distinguishes between cells that are merely metabolically active (as measured by MTT or LDH assays) and those that retain the capacity for indefinite proliferation—a hallmark of reproductive viability. The assay measures two key parameters: plating efficiency (PE), which reflects the inherent ability of cells to form colonies under control conditions, and surviving fraction (SF), which normalizes colony formation in treated groups to the control PE.

The assay is particularly valuable because it captures delayed or cumulative effects of treatments that may not be apparent in short-term assays. For example, in studies of silibinin in Detroit 562 cells, the colony formation assay revealed decreased long-term colony formation that correlated with apoptosis induction [1]. Similarly, in endometrial cancer research, sanguinarine chloride reduced colony formation through ferroptosis-mediated cell death [2]. The assay thus provides a functional readout of treatment efficacy that complements molecular endpoints.

Materials and Instrumentation Choices

Cell Culture Consumables

• Cell lines: Use authenticated, mycoplasma-free cell lines. Primary cells or low-passage lines are preferred for reproducibility.
• Culture medium: Complete medium appropriate for the cell line (e.g., DMEM or RPMI-1640 with 10% fetal bovine serum, 1% penicillin-streptomycin). Serum lot variation can affect PE; test new lots before use.
• Plates: 6-well plates are standard (9.5 cm² growth area per well). For higher throughput, 12-well or 24-well plates can be used, but colony size and counting accuracy may decrease.
• Trypsin/EDTA: 0.25% trypsin-EDTA for cell detachment. Over-trypsinization reduces viability; monitor under microscope.

Treatment Reagents

• Test compounds: Prepare stock solutions in appropriate solvent (DMSO, ethanol, or culture medium). Final solvent concentration should not exceed 0.1% (v/v) to avoid solvent toxicity.
• Positive control: A known cytotoxic agent (e.g., doxorubicin 1 µM, cisplatin 10 µM) to confirm assay sensitivity.
• Vehicle control: Solvent at the same concentration as in treated groups.

Fixation and Staining

• Fixative: 10% formalin (3.7% formaldehyde) or 100% methanol. Formalin preserves colony morphology better; methanol is faster but may cause shrinkage.
• Stain: 0.5% crystal violet in 25% methanol (w/v). Alternative: 0.1% methylene blue or Giemsa stain. Crystal violet provides high contrast for manual counting.
• Wash buffer: Phosphate-buffered saline (PBS) or distilled water.

Equipment

• CO₂ incubator: 37°C, 5% CO₂, humidified atmosphere. Temperature and CO₂ fluctuations affect colony growth; calibrate quarterly.
• Inverted microscope: For monitoring colony formation and counting. A 10× objective is sufficient for most colonies.
• Colony counter: Manual (gridded eyepiece) or automated (e.g., GelCount, ImageJ with ColonyArea plugin). Automated counters reduce subjectivity but require calibration.
• Hemocytometer or automated cell counter: For accurate cell seeding.

Controls

Proper controls are essential for interpreting colony formation data. Include the following in every experiment:

The positive control is critical for demonstrating that the assay can detect reduced colony formation. If the positive control does not show a significant reduction, the assay conditions (e.g., treatment duration, cell density) may need optimization.

Conceptual Workflow

Step 1: Cell Preparation and Seeding

1. Harvest cells at 70–80% confluence using trypsin-EDTA. Count viable cells using trypan blue exclusion.
2. Prepare a single-cell suspension at the desired density. For most adherent cell lines, seed 200–1000 cells per well in a 6-well plate. The optimal density depends on the cell line's plating efficiency and growth rate:
   • High PE (≥50%): 200–500 cells/well
   • Moderate PE (20–50%): 500–1000 cells/well
   • Low PE (<20%): 1000–2000 cells/well
3. Seed cells in triplicate for each condition. Gently swirl the plate to distribute cells evenly.
4. Incubate overnight (16–24 hours) to allow cell attachment before treatment.

Step 2: Treatment

1. Prepare treatment medium with the desired compound concentrations. Include a vehicle control and positive control.
2. Remove culture medium from wells and add treatment medium (2 mL for 6-well plates).
3. Incubate for the desired treatment duration (typically 24–72 hours). For long-term treatments, replace medium every 48–72 hours.
4. After treatment, remove treatment medium and wash cells gently with PBS (1 mL/well). Add fresh complete medium (2 mL/well).

Step 3: Colony Growth

1. Incubate cells for 7–14 days, replacing medium every 3–4 days. Monitor colony formation under an inverted microscope.
2. Colonies are typically visible after 5–7 days for fast-growing lines (e.g., HeLa) and may require 10–14 days for slower-growing lines (e.g., MCF-7).
3. Stop incubation when the largest colonies reach approximately 1–2 mm in diameter or when colonies in the control wells contain ≥50 cells. Avoid overgrowth, which leads to colony merging.

Step 4: Fixation and Staining

1. Remove culture medium and wash wells gently with PBS (1 mL/well).
2. Add fixative (1 mL/well for 6-well plates):
   • Formalin method: 10% formalin for 10–15 minutes at room temperature.
   • Methanol method: 100% methanol for 5–10 minutes at –20°C.
3. Remove fixative and wash with PBS or distilled water.
4. Add crystal violet stain (0.5% in 25% methanol, 500 µL/well) for 10–15 minutes at room temperature.
5. Remove stain and wash gently with distilled water until background is clear. Air-dry plates inverted on paper towels.

Step 5: Colony Counting

1. Count colonies manually under an inverted microscope or using an automated colony counter.
2. Define a colony as a cluster of ≥50 cells (approximately 0.5–1 mm diameter). Use a gridded eyepiece or ruler to standardize size.
3. For manual counting, mark counted colonies on the plate bottom with a permanent marker to avoid double-counting.
4. For automated counting, capture images with consistent lighting and use software parameters (e.g., minimum colony size, circularity threshold) validated against manual counts.

Step 6: Calculations

1. Plating Efficiency (PE) = (Number of colonies counted / Number of cells seeded) × 100%
   • Calculate PE for each control and treated well.
2. Surviving Fraction (SF) = PE of treated group / PE of control group
   • Normalize to the vehicle control PE.
3. Statistical analysis: Use one-way ANOVA with post-hoc tests (e.g., Dunnett's test) to compare treated groups to control. Report mean ± SD from triplicate wells.

Quality Checks

Perform the following checks to ensure assay validity:

Result Interpretation

Interpret colony formation data in the context of the experimental question:

• SF = 1.0: No effect on reproductive viability (treatment is non-toxic).
• SF < 1.0: Reduced reproductive viability (treatment is cytotoxic or cytostatic).
• SF > 1.0: Enhanced colony formation (possible hormesis or growth stimulation; verify with independent assays).

The surviving fraction is typically plotted on a logarithmic scale against treatment concentration to generate dose-response curves. The IC₅₀ (concentration that reduces SF to 0.5) can be calculated by nonlinear regression. In studies of ORC6L in breast cancer, colony formation assays showed that ORC6L overexpression increased colony numbers (SF > 1), while knockdown reduced colony formation (SF < 1), consistent with its oncogenic role [3].

Note that the colony formation assay measures only cells that survive and proliferate. It does not distinguish between cell death (apoptosis, necrosis, ferroptosis) and cell cycle arrest. Complementary assays (e.g., apoptosis assays, cell cycle analysis) are needed to determine the mechanism of reduced colony formation.

Troubleshooting

Limitations

The colony formation assay has several limitations that should be considered when designing experiments:

1. Time requirement: The assay takes 10–21 days, making it unsuitable for rapid screening.
2. Cell type dependency: Not all cell lines form discrete colonies. Some lines (e.g., suspension cells, primary cells) require modified protocols (e.g., semi-solid agar overlay).
3. Subjective counting: Manual counting is prone to operator bias. Automated counters reduce subjectivity but require validation.
4. Single-cell requirement: Clumps or doublets at seeding can produce false colonies. Verify single-cell suspension by microscopy.
5. Treatment duration: Short-term treatments (e.g., 1–2 hours) may not capture delayed effects. Consider continuous or repeated treatment for some applications.
6. Metabolic activity vs. proliferation: The assay does not distinguish between cells that are metabolically active but non-proliferating (e.g., senescent cells) and dead cells. As noted in UVGI studies, residual metabolic activity detected by MTT assay may indicate non-proliferating cells that do not form colonies [5].

Documentation

Maintain detailed records for reproducibility:

• Cell line: Source, passage number, mycoplasma testing date
• Culture medium: Formulation, serum lot number, antibiotic concentrations
• Seeding density: Cells per well, plate format, number of replicates
• Treatment: Compound name, stock concentration, solvent, final concentrations, treatment duration
• Incubation: Duration, medium change schedule, colony growth monitoring notes
• Fixation and staining: Fixative type, fixation time, stain type, staining time
• Counting method: Manual or automated, colony size threshold, software version
• Raw data: Colony counts per well, PE, SF calculations
• Statistical analysis: Test used, p-values, post-hoc comparisons

Include representative images of stained plates and colonies in laboratory notebooks or electronic records.

Biosafety Considerations

The colony formation assay is typically performed at BSL-1 for non-pathogenic, established cell lines (e.g., HeLa, MCF-7, Detroit 562). Follow standard BSL-1 practices as outlined in the CDC/NIH BMBL 6th Edition [6]:

• Personal protective equipment: Lab coat, gloves, safety glasses.
• Work area: Class II biological safety cabinet for cell culture procedures.
• Waste disposal: Decontaminate all liquid and solid waste with 10% bleach (30-minute contact time) before disposal.
• Cell line authentication: Use authenticated cell lines from reputable repositories (e.g., ATCC, ECACC). Test for mycoplasma contamination quarterly.
• Recombinant DNA: If using genetically modified cells (e.g., ORC6L overexpression constructs), follow NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [7]. Obtain institutional biosafety committee (IBC) approval before starting experiments.
• Chemical hazards: Formalin and crystal violet are hazardous. Work in a fume hood for fixation and staining steps. Dispose of chemical waste according to institutional guidelines.

For BSL-2 cell lines (e.g., those infected with low-risk viruses), additional containment measures are required. Consult the BMBL 6th Edition [6] and institutional biosafety officer for guidance.

Frequently Asked Questions

Q1: What is the minimum number of cells per colony for counting? A: The standard threshold is ≥50 cells per colony, which corresponds to approximately 5–6 cell divisions. Some protocols use ≥30 cells for slow-growing lines, but this reduces stringency. Always define the threshold in your methods and apply it consistently across all conditions.

Q2: Can I use the colony formation assay for suspension cells? A: Yes, but the protocol requires modification. Suspension cells are typically plated in semi-solid medium (e.g., 0.3% agar in culture medium) to prevent dispersal. This is called the soft agar colony formation assay and is commonly used for anchorage-independent growth studies. The standard protocol described here is for adherent cells only.

Q3: How do I choose the optimal seeding density? A: Perform a pilot experiment with 3–4 seeding densities (e.g., 200, 500, 1000, 2000 cells/well for a 6-well plate). After 10–14 days, select the density that yields 50–150 colonies per well in the control group. This density provides sufficient colonies for statistical analysis while minimizing overlap.

Q4: What is the difference between colony formation and cell proliferation assays (e.g., MTS, EdU)? A: Colony formation measures reproductive viability—the ability of a single cell to form a colony through multiple divisions over days to weeks. MTS and EdU assays measure metabolic activity or DNA synthesis over hours to days, which can detect short-term effects but may miss delayed cell death or growth arrest. Colony formation is more stringent and better reflects long-term treatment efficacy.

References and Further Reading

1. Talpos S, Chioran D, Alexandru GC, et al. Silibinin Triggers Mitochondrial Apoptosis and Declines Clonogenic Potential in Detroit 562 Human Pharyngeal Carcinoma Cells. (2025). https://pubmed.ncbi.nlm.nih.gov/41470199/

   • Demonstrates colony formation assay use in pharyngeal cancer cells treated with silibinin.

2. Li W, Liu S, Wang K, et al. Targeting the FTO-ACSL4 Pathway: A Novel Mechanism for Sanguinarine Chloride-Induced Ferroptosis in Endometrial Cancer. (2026). https://pubmed.ncbi.nlm.nih.gov/41898255/

   • Uses colony formation assay to evaluate sanguinarine chloride effects on endometrial cancer cells.

3. Jiang X, Wang S, Wei Q, et al. Novel Insights into the Oncogenic Role and Clinical Significance of ORC6L in Breast Cancer. (2026). https://pubmed.ncbi.nlm.nih.gov/42039914/

   • Applies colony formation assay to study ORC6L function in breast cancer cell lines.

4. Ko CC, Gauger PC, Rigby S, et al. Comparative evaluation and validation of rapid quantification methods for Mycoplasma hyopneumoniae: development of a PMA-based viability qPCR assay. (2026). https://pubmed.ncbi.nlm.nih.gov/41765967/

   • Discusses colony-forming unit (CFU) enumeration as a reference method for bacterial quantification.

5. Sadanandan B, Sunder S, Vijayalakshmi V, et al. Design of a Wireless Ultraviolet Germicidal Irradiation System and Validation of Germicidal Potential Against Biofilm-Forming Bacteria and Fungi. (2026). https://pubmed.ncbi.nlm.nih.gov/42192729/

   • Uses CFU enumeration for microbial viability assessment; notes differences between CFU and metabolic assays.

6. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services (2020). https://www.cdc.gov/labs/bmbl/index.html

   • Authoritative guidelines for biosafety practices in cell culture laboratories.

7. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/

   • Regulatory framework for work with genetically modified cells.

8. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. https://www.ncbi.nlm.nih.gov/books/

   • Searchable collection of methods references for cell biology and molecular techniques.

Related Articles

• LDH Assay: Protocol for Measuring Cytotoxicity and Cell Viability
• MTS Assay Protocol: Cell Proliferation and Viability Measurement
• Transwell Migration Assay Protocol: Measuring Cell Migration and Invasion
• Kinase Activity Assay: Methods for Measuring Protein Kinase Activity
• Enzyme Activity Assay: Principles and Protocol for Measuring Catalytic Activity
• Lowry Assay Protocol: Protein Quantification Method